VOYA Investment Management’s Seres Therapeutics MCRB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,653
Closed -$25.6K 2877
2024
Q1
$25.6K Sell
1,653
-374
-18% -$8.06K ﹤0.01% 2774
2023
Q4
$56.7K Hold
2,027
﹤0.01% 2837
2023
Q3
$96.5K Buy
2,027
+87
+4% +$6.64K ﹤0.01% 2742
2023
Q2
$186K Buy
1,940
+561
+41% +$61K ﹤0.01% 2616
2023
Q1
$156K Hold
1,379
﹤0.01% 2608
2022
Q4
$154K Hold
1,379
﹤0.01% 2646
2022
Q3
$177K Hold
1,379
﹤0.01% 2638
2022
Q2
$95K Hold
1,379
﹤0.01% 2630
2022
Q1
$196K Hold
1,379
﹤0.01% 2375
2021
Q4
$230K Buy
1,379
+12
+0.9% +$1.91K ﹤0.01% 2430
2021
Q3
$190K Hold
1,367
﹤0.01% 2593
2021
Q2
$652K Buy
1,367
+168
+14% +$70.9K ﹤0.01% 1928
2021
Q1
$494K Buy
1,199
+23
+2% +$10.6K ﹤0.01% 2045
2020
Q4
$576K Buy
1,176
+280
+31% +$164K ﹤0.01% 1830
2020
Q3
$508K Buy
896
+117
+15% +$38.9K ﹤0.01% 1671
2020
Q2
$74K Sell
779
-185
-19% -$16.2K ﹤0.01% 2381
2020
Q1
$69K Hold
964
﹤0.01% 2430
2019
Q4
$67K Buy
964
+280
+41% +$20.8K ﹤0.01% 2613
2019
Q3
$55K Buy
684
+178
+35% +$11.8K ﹤0.01% 2491
2019
Q2
$33K Hold
506
﹤0.01% 2574
2019
Q1
$69K Hold
506
﹤0.01% 2488
2018
Q4
$46K Hold
506
﹤0.01% 2498
2018
Q3
$77K Hold
506
﹤0.01% 2529
2018
Q2
$87K Hold
506
﹤0.01% 2538
2018
Q1
$74K Hold
506
﹤0.01% 2514
2017
Q4
$103K Hold
506
﹤0.01% 2496
2017
Q3
$162K Hold
506
﹤0.01% 2451
2017
Q2
$114K Buy
+506
New +$104K ﹤0.01% 2543
2016
Q3
Sell
-389
Closed -$226K 2544
2016
Q2
$226K Buy
+389
New +$228K ﹤0.01% 2190

Other funds holding MCRB

VOYA Investment Management's MCRB Position: Q2 2024 in Review

VOYA Investment Management sold out of Seres Therapeutics (MCRB) in Q2 2024, closing a stake of 1,653 shares — an estimated $25.6K sold.

VOYA Investment Management first reported a position in MCRB in Q2 2016 and held it in 29 quarters. The position peaked at $652K in Q2 2021. 93 funds tracked by Wall St. Rank hold MCRB as of Q2 2024.

  • VOYA Investment Management reported no remaining Seres Therapeutics position as of Q2 2024 after selling out during the quarter.
  • VOYA Investment Management sold 1,653 Seres Therapeutics shares in Q2 2024, an estimated $25.6K.
  • VOYA Investment Management first reported a position in Seres Therapeutics in Q2 2016 and held it in 29 quarters.
  • VOYA Investment Management's Seres Therapeutics position peaked at $652K in Q2 2021.
  • 93 funds tracked by Wall St. Rank held Seres Therapeutics as of Q2 2024.

Based on VOYA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.